Cytokinetics Overview
Cytokinetics Target Price
Analysts' 12-month price predictions for CYTK.
Share Price
$30.61
Average Target Price
$61.00
99.3% upside
99.3% upside2 analysts in the last 4 months
High: $67 | Low: $55
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-24 | BarclaysGena Wang | $55 | 79.7% upside |  |
| 2025-03-07 | Morgan Stanley | $67 | 118.9% upside | |
| 2024-10-17 | H.C. WainwrightJoseph Pantginis | $120 | 292% upside | |
| 2024-09-03 | Goldman SachsPaul Choi | $60 | 96% upside | |
| 2024-06-10 | Piper SandlerYasmeen Rahimi | $107 | 249.6% upside | |
| 2024-06-04 | B.Riley FinancialMayank Mamtani | $92 | 200.6% upside | |
| 2024-05-28 | JMP SecuritiesJason Butler | $78 | 154.8% upside | |
| 2024-05-23 | H.C. WainwrightJoseph Pantginis | $90 | 194% upside | |
| 2024-05-23 | NeedhamSerge Belanger | $72 | 135.2% upside | |
| 2024-05-23 | JefferiesAkash Tewari | $85 | 177.7% upside | |
| 2024-05-23 | BarclaysCarter Gould | $95 | 210.4% upside | |
| 2024-05-09 | OppenheimerJustin Kim | $106 | 246.3% upside | |
| 2024-05-09 | JMP SecuritiesJason Butler | $106 | 246.3% upside | |
| 2024-04-05 | Mizuho SecuritiesSalim Syed | $99 | 223.4% upside | |
| 2022-12-23 | Needham | $58 | 89.5% upside | |
| 2022-12-20 | Truist Financial | $60 | 96% upside | |
| 2022-08-23 | Raymond JamesDane Leone | $63 | 105.8% upside | |
| 2022-06-09 | Piper SandlerYasmeen Rahimi | $72 | 135.2% upside | |
| 2022-04-30 | H.C. WainwrightJoseph Pantginis | $75 | 145% upside | |
| 2021-12-20 | BarclaysCarter Gould | $52 | 69.9% upside | |
| 2021-11-18 | Raymond JamesDane Leone | $54 | 76.4% upside | |
| 2021-10-08 | Morgan StanleyJeffrey Hung | $45 | 47% upside | |